REMPEVRY

Serial Number 99170033
688

Registration Progress

Application Filed
May 5, 2025
Under Examination
Nov 18, 2025
Approved for Publication
Sep 23, 2025
Published for Opposition
Sep 23, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: May 18, 2026 135 days

Trademark Image

REMPEVRY

Basic Information

Serial Number
99170033
Filing Date
May 5, 2025
Published for Opposition
September 23, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Nov 18, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Tiffany Trunko

USPTO Deadlines

Next Deadline
135 days remaining
NOA E-Mailed - SOU Required
Due Date
May 18, 2026
Extension Available
Until November 18, 2026

Application History

15 events
Date Code Type Description Documents
Nov 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 23, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 23, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 17, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 22, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 20, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 20, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 1, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 30, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 5, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 5, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Classification

International Classes
005